#151106

Anti-PLAP [HD 11F7]

Cat. #151106

Anti-PLAP [HD 11F7]

Cat. #: 151106

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 1-2 weeks

Target: Placental alkaline phosphatase (PLAP)

Class: Monoclonal

Application: ELISA ; IHC ; RIA

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Walter Bodmer

Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY

  • Name: Anti-PLAP [HD 11F7]
  • Alternate name: Integrin Subunit Alpha 2; Alpha 2 Subunit Of VLA-2 Receptor; Platelet Membrane Glycoprotein Ia; CD49 Antigen-Like Family Member B; Collagen Receptor; CD49B; GPIa; Very Late Activation Protein 2 Receptor, Alpha-2 Subunit; Human Platelet Alloantigen System 5; Platelet Glycoprotein GPIa; Platelet Antigen Br; VLA-2 Subunit Alpha; CD49b Antigen; HPA-5; VLA-2; VLAA2; BR
  • Clone: HD 11F7
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Strain: Balb/c
  • Reactivity: Human
  • Host: Mouse
  • Application: ELISA ; IHC ; RIA
  • Description: Monoclonal antibody with potential use in detection of ovarian and testicular tumours via detection of PLAP.
  • Immunogen: Fresh Hep-2 cells followed by booster injections of fresh Hep-2 cells that had their surface expression of PLAP boosted in culture.
  • Immunogen uniprot id: P05187
  • Isotype: IgG2b
  • Myeloma used: P3/NS1/1-Ag4.1

Target Details

  • Target: Placental alkaline phosphatase (PLAP)
  • Target background: Human placental alkaline phosphatase (PLAP) is a membrane bound glycosylated phosphodiesterase normally synthesised by syncytiotrophoblast from the 12th week of pregnancy. Since its identification as an oncofoetal antigen, it has been found to be expressed by malignant tumours of germ cell and non-germ cell origin. The detection of alkaline phosphatase in serum is a marker for ovarian and testicular cancer. HD 11F7 has potential uses in the diagnosis of ovarian and testicular tumours. This antibody detects both Regan and Nagao isoenzymes. The placental-specific isozyme of Alkaline Phosphatase (PLAP), also referred to as the heat-stable form, is found in trophoblast cells of normal human mature placenta, seminomas of testis and ovarian carcinomas. It is closely related to the intestinal form of the enzyme as well as to the placental-like form. Anti-PLAP was created for use in immunoscintigraphy or therapy.

Applications

  • Application: ELISA ; IHC ; RIA

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: Store at -20° C frozen. Avoid repeated freeze / thaw cycles
  • Shipping conditions: Shipping at 4° C

References

  • Fitzgerald et al. 2018. Am J Reprod Immunol. 80(1):e12860. PMID: 29726582.
  • Durbin et al. 1988. Int J Cancer Suppl. 2:59-66. PMID: 3162446.
  • Monoclonal antibodies to placental alkaline phosphatase: preclinical evaluation in a human xenograft tumour model of F(ab')2 and Fab fragments.